These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

295 related articles for article (PubMed ID: 2975216)

  • 1. Factors involved in the pathogenesis of hypertensive cardiovascular hypertrophy. A review.
    Dahlöf B
    Drugs; 1988; 35 Suppl 5():6-26. PubMed ID: 2975216
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Effect of cilazapril, a converting enzyme inhibitor, on cardiovascular hypertrophy in the hypertensive patient].
    Sesin J; Tamargo J
    Medicina (B Aires); 1996; 56(1):75-84. PubMed ID: 8734937
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Coronary vascular changes in the progression and regression of hypertensive heart disease.
    Strauer BE; Schwartzkopff B; Motz W; Vogt M
    J Cardiovasc Pharmacol; 1991; 18 Suppl 3():S20-7. PubMed ID: 1720480
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Left ventricular hypertrophy in arterial hypertension].
    Garnier LF; François G; Lang M; Raynaud P; Brochier M
    Presse Med; 1988 Feb; 17(7):333-8. PubMed ID: 2966353
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The role of antihypertensive pharmacologic treatment in countering adverse pathophysiological profiles: influence on small arteries.
    Dahlöf B
    Am Heart J; 1987 Oct; 114(4 Pt 2):984-91. PubMed ID: 3661387
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Relation of renin-angiotensin system activity to left ventricular hypertrophy and function in experimental and human hypertension.
    Devereux RB; Pickering TG; Cody RJ; Laragh JH
    J Clin Hypertens; 1987 Mar; 3(1):87-103. PubMed ID: 3033158
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reversal of left ventricular hypertrophy: a desirable therapeutic goal?
    Schmieder RE; Messerli FH
    J Cardiovasc Pharmacol; 1990; 16 Suppl 6():S16-22. PubMed ID: 1707110
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Regression of cardiac hypertrophy with drug treatment in spontaneously hypertensive rats.
    Ruskoaho H
    Med Biol; 1984; 62(5):263-76. PubMed ID: 6152298
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Regression of left ventricular hypertrophy in patients with hypertension.
    Balogun MO; Dunn FG
    J Hum Hypertens; 1990 Oct; 4 Suppl 4():29-32; discussion 32-4. PubMed ID: 2149391
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparative analysis of cardiac function, geometry, energetics and coronary reserve in hypertensive heart disease.
    Strauer BE
    Nephron; 1987; 47 Suppl 1():76-86. PubMed ID: 2962004
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Physiopathology of arterial hypertension. Significance of the renin-angiotensin-aldosterone system and structural changes].
    Fernandes A
    Rev Port Cardiol; 1989 Apr; 8(4):275-80. PubMed ID: 2534357
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of angiotensin II blockade on cardiac hypertrophy and remodelling: a review.
    Dahlöf B
    J Hum Hypertens; 1995 Nov; 9 Suppl 5():S37-44. PubMed ID: 8583480
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Structural and functional adaptation in the rat myocardium and coronary vascular bed caused by changes in pressure and volume load.
    Friberg P
    Acta Physiol Scand Suppl; 1985; 540():1-47. PubMed ID: 3161269
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Echocardiography in clinical pharmacology: developing new concepts on the pathophysiology of left ventricular hypertrophy in arterial hypertension.
    Corea L; Bentivoglio M; Verdecchia P; Motolese M
    Int J Clin Pharmacol Res; 1983; 3(3):157-61. PubMed ID: 6237069
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cardiovascular hypertrophy in spontaneously hypertensive rats.
    Sen S; Tarazi RC
    J Hypertens Suppl; 1986 Oct; 4(3):S123-6. PubMed ID: 2946822
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Is arterial pressure the sole factor responsible for hypertensive cardiac hypertrophy?
    Frohlich ED; Tarazi RC
    Am J Cardiol; 1979 Oct; 44(5):959-63. PubMed ID: 158971
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Hypertensive cardiopathy. Functional evaluation during isometric effort after regression of left ventricular hypertrophy].
    Nogueira JB; Freitas A; Morais C; Silva D; Esteves J; da Costa JN
    Rev Port Cardiol; 1992 Mar; 11(3):229-38. PubMed ID: 1535203
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Risk for cardiac involvement in essential hypertension.
    Zahka KG
    Cardiol Clin; 1986 Feb; 4(1):81-93. PubMed ID: 2939953
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The molecular basis of cardiovascular hypertrophy: the role of the renin-angiotensin system.
    Paul M; Ganten D
    J Cardiovasc Pharmacol; 1992; 19 Suppl 5():S51-8. PubMed ID: 1381795
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of the cardiac renin-angiotensin system in hypertensive cardiac hypertrophy.
    Lee YA; Lindpaintner K
    Eur Heart J; 1993 Nov; 14 Suppl J():42-8. PubMed ID: 8281962
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.